These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3356294)

  • 1. In vitro activation of the contact activation system (Hageman factor system) in plasma by acidic phospholipids and the inhibitory effect of beta 2-glycoprotein I on this activation.
    Schousboe I
    Int J Biochem; 1988; 20(3):309-15. PubMed ID: 3356294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation.
    Schousboe I; Rasmussen MS
    Int J Biochem; 1988; 20(8):787-92. PubMed ID: 3169363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein I.
    Henry ML; Everson B; Ratnoff OD
    J Lab Clin Med; 1988 May; 111(5):519-23. PubMed ID: 3361230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phospholipid vesicles in the blood coagulation process in vitro.
    Ueno M; Kimura M; Nozima Y; Horikoshi I
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4570-2. PubMed ID: 7168877
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylethanolamine and phosphatidylserine synergistically promote heparin's anticoagulant effect.
    van den Besselaar AM
    Blood Coagul Fibrinolysis; 1995 May; 6(3):239-44. PubMed ID: 7654938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
    Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
    Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of phospholipids in activating and inhibiting the blood coagulation process].
    Karagezian KG; Ovakimian SS; Tevosiants AV
    Dokl Akad Nauk SSSR; 1971 Nov; 201(2):486-9. PubMed ID: 5131109
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of phospholipids on the activity of ornithine decarboxylase from rat liver.
    Kitani T; Fujisawa H
    FEBS Lett; 1981 Sep; 132(2):296-8. PubMed ID: 7297700
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen induction and contact phase activation of human factor XII.
    Citarella F; Misiti S; Felici A; Farsetti A; Pontecorvi A; Fantoni A
    Steroids; 1996 Apr; 61(4):270-6. PubMed ID: 8733013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of brain cortex phospholipids on adenylate-cyclase activity of mouse brain.
    Leon A; Benvegnù D; Toffano G; Orlando P; Massari P
    J Neurochem; 1978 Jan; 30(1):23-6. PubMed ID: 202678
    [No Abstract]   [Full Text] [Related]  

  • 13. beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.
    Schousboe I
    Blood; 1985 Nov; 66(5):1086-91. PubMed ID: 4052628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the coagulant activities of platelets and phospholipids.
    Walsh PN; Lipscomb MS
    Br J Haematol; 1976 May; 33(1):9-18. PubMed ID: 1268092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phospholipids on lipase activity in rat arterial wall homogenate.
    Shirai K; Matsuoka N; Saito Y; Kumagai A
    Tohoku J Exp Med; 1982 Oct; 138(2):131-7. PubMed ID: 7179271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Hageman factor by collagen.
    Wilner GD; Nossel HL; LeRoy EC
    J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X-prothrombin system.
    Tsuda T; Yoshimura H; Hamasaki N
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):465-9. PubMed ID: 16905950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asbestos fibers, plasma and inflammation.
    Hamilton JA
    Environ Health Perspect; 1983 Sep; 51():281-5. PubMed ID: 6641659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.